Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 study.

Zinzani, P L; Vose, J M; Czuczman, M S; Reeder, C B; Haioun, C; Polikoff, J; Tilly, H; Zhang, L; Prandi, K; Li, J; Witzig, T E.

Ann Oncol ; 24(11): 2892-7, 2013 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-24030098

2.

Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion.

Mian, M; Scandurra, M; Chigrinova, E; Shen, Y; Inghirami, G; Greiner, T C; Chan, W C; Vose, J M; Testoni, M; Chiappella, A; Baldini, L; Ponzoni, M; Ferreri, A J M; Franceschetti, S; Gaidano, G; Montes-Moreno, S; Piris, M A; Facchetti, F; Tucci, A; Nomdedeu, J Fr; Lazure, T; Uccella, S; Tibiletti, M G; Zucca, E; Kwee, I; Bertoni, F.

Ann Oncol ; 23(3): 729-735, 2012 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-21693768

3.

An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma.

Witzig, T E; Vose, J M; Zinzani, P L; Reeder, C B; Buckstein, R; Polikoff, J A; Bouabdallah, R; Haioun, C; Tilly, H; Guo, P; Pietronigro, D; Ervin-Haynes, A L; Czuczman, M S.

Ann Oncol ; 22(7): 1622-1627, 2011 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-21228334

4.

A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma.

Younes, A; Vose, J M; Zelenetz, A D; Smith, M R; Burris, H A; Ansell, S M; Klein, J; Halpern, W; Miceli, R; Kumm, E; Fox, N L; Czuczman, M S.

Br J Cancer ; 103(12): 1783-7, 2010 Dec 07.

Artigo em Inglês | MEDLINE | ID: mdl-21081929

5.

The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project.

Suzumiya, J; Ohshima, K; Tamura, K; Karube, K; Uike, N; Tobinai, K; Gascoyne, R D; Vose, J M; Armitage, J O; Weisenburger, D D.

Ann Oncol ; 20(4): 715-21, 2009 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-19150954

6.

Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma.

Iqbal, J; Greiner, T C; Patel, K; Dave, B J; Smith, L; Ji, J; Wright, G; Sanger, W G; Pickering, D L; Jain, S; Horsman, D E; Shen, Y; Fu, K; Weisenburger, D D; Hans, C P; Campo, E; Gascoyne, R D; Rosenwald, A; Jaffe, E S; Delabie, J; Rimsza, L; Ott, G; Müller-Hermelink, H K; Connors, J M; Vose, J M; McKeithan, T; Staudt, L M; Chan, W C.

Leukemia ; 21(11): 2332-43, 2007 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-17625604

7.

Correlation of secondary cytogenetic abnormalities with histologic appearance in non-Hodgkin's lymphomas bearing t(14;18)(q32;q21).

Armitage, J O; Sanger, W G; Weisenburger, D D; Harrington, D S; Linder, J; Bierman, P J; Vose, J M; Purtilo, D T.

J Natl Cancer Inst ; 80(8): 576-80, 1988 Jun 15.

Artigo em Inglês | MEDLINE | ID: mdl-3259635

8.

Recurrent activating mutations of CD28 in peripheral T-cell lymphomas.

Rohr, J; Guo, S; Huo, J; Bouska, A; Lachel, C; Li, Y; Simone, P D; Zhang, W; Gong, Q; Wang, C; Cannon, A; Heavican, T; Mottok, A; Hung, S; Rosenwald, A; Gascoyne, R; Fu, K; Greiner, T C; Weisenburger, D D; Vose, J M; Staudt, L M; Xiao, W; Borgstahl, G E O; Davis, S; Steidl, C; McKeithan, T; Iqbal, J; Chan, W C.

Leukemia ; 30(5): 1062-70, 2016 05.

Artigo em Inglês | MEDLINE | ID: mdl-26719098

9.

Clinical applications of hematopoietic growth factors.

Vose, J M; Armitage, J O.

J Clin Oncol ; 13(4): 1023-35, 1995 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-7535842

10.

Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.

Coiffier, B; Gisselbrecht, C; Vose, J M; Tilly, H; Herbrecht, R; Bosly, A; Armitage, J O.

J Clin Oncol ; 9(2): 211-9, 1991 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-1703226

11.

High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma.

Bierman, P J; Vose, J M; Anderson, J R; Bishop, M R; Kessinger, A; Armitage, J O.

J Clin Oncol ; 15(2): 445-50, 1997 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-9053464

12.

Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991.

Bennett, C L; Armitage, J L; Armitage, G O; Vose, J M; Bierman, P J; Armitage, J O; Anderson, J R.

J Clin Oncol ; 13(4): 969-73, 1995 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-7707125

13.

Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma.

Yan, Y; Chan, W C; Weisenburger, D D; Anderson, J R; Bast, M A; Vose, J M; Bierman, P J; Armitage, J O.

J Clin Oncol ; 13(6): 1336-42, 1995 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-7751877

14.

High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.

Vose, J M; Anderson, J R; Kessinger, A; Bierman, P J; Coccia, P; Reed, E C; Gordon, B; Armitage, J O.

J Clin Oncol ; 11(10): 1846-51, 1993 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-8105034

15.

CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity.

Vose, J M; Bierman, P J; Anderson, J R; Weisenburger, D; Moravec, D F; Sorensen, S; Hutchins, M; Dowling, M D; Howe, D; Okerbloom, J.

J Clin Oncol ; 9(8): 1421-5, 1991 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-2072145

16.

Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial.

Vose, J M; Reed, E C; Pippert, G C; Anderson, J R; Bierman, P J; Kessinger, A; Spinolo, J; Armitage, J O.

J Clin Oncol ; 11(7): 1306-10, 1993 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-8315426

17.

Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group.

Anderson, J R; Vose, J M; Bierman, P J; Weisenberger, D D; Sanger, W G; Pierson, J; Bast, M; Armitage, J O.

J Clin Oncol ; 11(2): 218-24, 1993 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-8426197

18.

Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease.

Bierman, P J; Vose, J M; Leichner, P K; Quadri, S M; Armitage, J O; Klein, J L; Abrams, R A; Dicke, K A; Vriesendorp, H M.

J Clin Oncol ; 11(4): 698-703, 1993 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-8478663

19.

Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma.

Armitage, J O; Vose, J M; Linder, J; Weisenburger, D; Harrington, D; Casey, J; Bierman, P; Sorensen, S; Hutchins, M; Moravec, D F.

J Clin Oncol ; 7(12): 1783-90, 1989 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-2585020

20.

The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.

Vose, J M; Armitage, J O; Weisenburger, D D; Bierman, P J; Sorensen, S; Hutchins, M; Moravec, D F; Howe, D; Dowling, M D; Mailliard, J.

J Clin Oncol ; 6(12): 1838-44, 1988 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-2462026

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: